196 related articles for article (PubMed ID: 22490991)
1. Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals.
Mantovani A; Zoppini G; Targher G; Golia G; Bonora E
J Endocrinol Invest; 2012 Feb; 35(2):215-8. PubMed ID: 22490991
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease.
Targher G; Pichiri I; Zoppini G; Trombetta M; Bonora E
J Endocrinol Invest; 2012 May; 35(5):535-40. PubMed ID: 21795844
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.
Fallo F; Dalla Pozza A; Sonino N; Lupia M; Tona F; Federspil G; Ermani M; Catena C; Soardo G; Di Piazza L; Bernardi S; Bertolotto M; Pinamonti B; Fabris B; Sechi LA
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):646-53. PubMed ID: 19278843
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.
Gerdts E; Okin PM; Omvik P; Wachtell K; Dahlöf B; Hildebrandt P; Nieminen MS; Devereux RB
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):306-12. PubMed ID: 19303268
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E
J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.
Lutale JJ; Thordarson H; Gulam-Abbas Z; Vetvik K; Gerdts E
Cardiovasc J Afr; 2008; 19(1):8-14. PubMed ID: 18320079
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study.
Parsa N; Moheb M; Zibaeenezhad MJ; Karimi-Akhormeh A; Trevisan M; Wallin L; Zaheri PM; Sayadi M; Razeghian-Jahromi I; Moaref A
BMC Cardiovasc Disord; 2023 Feb; 23(1):88. PubMed ID: 36792995
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
Mantovani A; Pernigo M; Bergamini C; Bonapace S; Lipari P; Pichiri I; Bertolini L; Valbusa F; Barbieri E; Zoppini G; Bonora E; Targher G
PLoS One; 2015; 10(8):e0135329. PubMed ID: 26252899
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus.
Bonapace S; Valbusa F; Bertolini L; Pichiri I; Mantovani A; Rossi A; Zenari L; Barbieri E; Targher G
PLoS One; 2014; 9(2):e88371. PubMed ID: 24505484
[TBL] [Abstract][Full Text] [Related]
13. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure.
Wang Y; Yang H; Huynh Q; Nolan M; Negishi K; Marwick TH
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1390-1400. PubMed ID: 29778859
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver.
Targher G; Pichiri I; Zoppini G; Trombetta M; Bonora E
Diabet Med; 2012 Feb; 29(2):220-6. PubMed ID: 21883436
[TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda.
Nabbaale J; Kibirige D; Ssekasanvu E; Sebatta ES; Kayima J; Lwabi P; Kalyesubula R
BMC Res Notes; 2015 May; 8():198. PubMed ID: 25971452
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease Is Related to Abnormal Corrected QT Interval and Left Ventricular Hypertrophy in Chinese Male Steelworkers.
Hung WC; Yu TH; Wu CC; Lee TL; Tang WH; Chen CC; Lu IC; Chung FM; Lee YJ; Hsu CC
Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361436
[TBL] [Abstract][Full Text] [Related]
19. Association of Urinary Sodium Excretion and Left Ventricular Hypertrophy in People With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Liu J; Yang X; Zhang P; Guo D; Xu B; Huang C; Xue Y; Zhang H
Front Endocrinol (Lausanne); 2021; 12():728493. PubMed ID: 34650519
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
